echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Cansino: Group A and C meningococcal polysaccharide conjugate vaccine obtained drug registration certificate

    Cansino: Group A and C meningococcal polysaccharide conjugate vaccine obtained drug registration certificate

    • Last Update: 2021-08-11
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On June 23, Cansino announced that it had obtained the "Drug Registration Certificate" issued by the State Food and Drug Administration for the Group A and C Meningococcal Polysaccharide Conjugate Vaccine


    Meningococcal disease is a serious infectious disease mainly caused by Neisseria meningitidis, with the highest incidence among infants and young children under 12 months of age


    The main meningococcal vaccine in China is meningococcal polysaccharide vaccine (MPSV), including MPSV2 and MPSV4


    The company's MCV2 has completed phase I and phase III clinical trials, and the phase I clinical results initially show that the company's MCV2 has good safety and tolerability in various age groups


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.